SlideShare a Scribd company logo
PROTEIN BINDING
Physical pharmaceutics
PROTEIN BINDING
● The phenomenon of complex formation of drug
with protein is called protein binding.
● A protein bound drug is neither metabolised
nor excreted hence it is pharmacologically
inactive.
● Protein + drug = Protein drug complex
Protein binding may be divided into
two groups-
● Reversible binding- The drug binds the
Protein with weak bonds such as-
hydrogen bonds or van der waals forces.
● These type of drugs can unbound and
shows its therapeutic action.
● Irreversible binding- The drug binds
with protein by strong covalent
bonding and often a reason for the
carcinogenicity and toxicity.
● Order of binding of drug with
protein:
Albumin > glycoprotein >lipoprotein>
globulin
● Binding of drugs to albumin
2.Digoxine
1. Warfarin & site
Azapropazone
4.Diazepam
sit
3. Tamoxifen
site
● Significance of protein binding with drug:-
● Absorption- When there is more protein binding
by the drug then it will distrub the absorption
equilibrium.
● The rate of absorption is decreased when
protein is bind with drug.
● Distribution- The protein bound drug doesn’t
cross the BBB, placental barrier and glomerulus.
Thus it decrease the distribution of drug.
Metabolism- Protein binding decreases the
metabolism of drug and enhance the biological half
life. Only unbound fraction get metabolised.
Elimination- Only the unbound druf is capable of
being eliminated. Protein binding prevent the entry
of drug to the metabolizing organ (liver) and
glomerulus filtration.
Systemic solubility of drug – Lipoprotein act as
vehicle for hydrophobic drugs like steriods,heparin,
oil soluble vitamins.
Drug action- Protein binding inactivates the
drug because sufficient concentration of drug
cannot be build up in the receptor site for
action.
Diagnisis – The chlorine atom of chloroquine
replaced with radiolabeled l-131cab be used to
visualise melanomas of eyes and disorders of
thyroid gland.
Factors affecting protein binding
Drug related factors:
1. Physiochemical factors of drug- Binding affinity depend on physical and
chemical properties of drug.
Increase in lipophilicity Increase the drug binding with the protein.
2. Concentration of drug- Alteration in concentration of drug substance
as well as the protein molecules cause alteration in protein binding.
At low concentration, most drug may bound to protein.
At high concentration, more free drug may present owing to saturation
of binding site on protein.
3. Affinity of drug for binding component-
● This depend on affinity of protein molecule to bind to drug.
● Eg. Digoxine hascmore affinity for protein of cardiac muscle
than those of skeletal muscles.
● Factors related to protein:
1.Physiochemical property- Lipoprotein bind with lipophilic drug.
2. Concentration of protein- Disease state affect the
concentration of protein in blood. It Increase the concentration of
protein and protein binding in the body.
3.No. Of binding sites- Presence of more binding sites in protein
increase protein binding of drug.
Eg Albumin has more no. Of binding site.
● Factors related to age:
1.Age- Neonata have low albumin content thus less drug binding.
2. Disease state- Disease states increase the Albumin thus
increse protein binding.
Method of measuring the unbound drug concentration
● Equilibrium dialysis method
● In this method the Albumin is placed in visking cellulose bag and drug in
different concentration is placed in the outside vessel.
● As the dialysis continue, the drug molecules permeate through the
membrane and enter into the bag.
● As a result the dryg protein binding is observed. Albumin being
macromolecules can’t pass through the membrane to outside vessel.
● As time ellapsis more amount of drug permeate and available in the bag.
● If binding occurs the drug concentration in the body containing protein
should be greater than its concentration in the outside vessel.
1. Equilibrium dialysis method
2. Dynamic dialysis method:
● The apparatus consist of a 400ml jacketed (with a temperature control)
beaker into which 200ml of buffer solution is placed.
● Around 70ml of drug (blank) and drug protein solution is placed in a dialysis
bag and suspended in the buffer solution. The solution is is stir
continuously.
● During dialysis the free drug present in the bag permeate through the
membrane and reaches the buffer solution.
● Such a transport shift the equilibrium in favour of full drug molecules in the
bag.
● Every 5 or 10 mins. Sample of solution are withdrawn from the beaker and
an equivalent quantity of buffer solution is return to the beaker
● The amount of drug present in the solution is estimated by a suitable
method (UV rays)
2. Dynamic dialysis method:
PROTEIN BINDING

More Related Content

What's hot

Complexation and protein binding
Complexation and protein bindingComplexation and protein binding
Complexation and protein binding
Mahewash Sana Pathan
 
Enzyme induction and inhibition
Enzyme induction and inhibitionEnzyme induction and inhibition
Enzyme induction and inhibition
Manjari Bodasu
 
Complexation & protein binding
Complexation & protein bindingComplexation & protein binding
Complexation & protein binding
JILSHA123
 
kinetics of protein binding.pptx
kinetics of protein binding.pptxkinetics of protein binding.pptx
kinetics of protein binding.pptx
GitanjaliMehetre1
 
Physicochemical properties of drug molecules
Physicochemical properties of drug moleculesPhysicochemical properties of drug molecules
Physicochemical properties of drug molecules
Mahewash Sana Pathan
 
Protein Drug Binding
Protein Drug BindingProtein Drug Binding
Protein Drug Binding
Ganesh Gadilohar
 
Surface and interfacial phenomenon
Surface and interfacial  phenomenonSurface and interfacial  phenomenon
Surface and interfacial phenomenon
RAHUL PAL
 
Unit IV MICROMERITICS
Unit IV MICROMERITICSUnit IV MICROMERITICS
Unit IV MICROMERITICS
VijayaKumarR28
 
Thixotropy (1) (1)
Thixotropy (1) (1)Thixotropy (1) (1)
Thixotropy (1) (1)
madnanqaisrani
 
Solubility of drugs
Solubility of drugsSolubility of drugs
Solubility of drugs
Mirza Salman Baig
 
Deformation of solids (Physical Pharmaceutics)
Deformation of solids (Physical Pharmaceutics)Deformation of solids (Physical Pharmaceutics)
Deformation of solids (Physical Pharmaceutics)
MAYANK ,MEHENDIRATTA
 
Ideal solubility parameter (solubility of drug part 2)
Ideal solubility parameter (solubility of drug part 2)Ideal solubility parameter (solubility of drug part 2)
Ideal solubility parameter (solubility of drug part 2)
Ms. Pooja Bhandare
 
ELIMINATION OF DRUGS BIOPHARMACEUTICS
ELIMINATION OF DRUGS BIOPHARMACEUTICSELIMINATION OF DRUGS BIOPHARMACEUTICS
ELIMINATION OF DRUGS BIOPHARMACEUTICS
NEW ROYAL CARE PHARMACY, SALEM, TAMILNADU, INDIA - 636011
 
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th semMedicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
snigdharanibehera
 
Ph, buffers & isotonic solution
Ph, buffers & isotonic solutionPh, buffers & isotonic solution
Ph, buffers & isotonic solution
Ali-Allana college of pharmacy Akkalkuwa
 
Mechanism of solute solvent interaction
Mechanism of solute solvent interactionMechanism of solute solvent interaction
Mechanism of solute solvent interaction
VickyLone1
 
kinetics and drug stability
kinetics and drug stability kinetics and drug stability
kinetics and drug stability
Raju Sanghvi
 
Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokinetics
Snehal Patel
 
Suspension, type of suspension, interracial property of suspended particles
Suspension, type of suspension, interracial property of suspended particles Suspension, type of suspension, interracial property of suspended particles
Suspension, type of suspension, interracial property of suspended particles
Dheeraj Saini
 
Rotational viscometers
Rotational viscometersRotational viscometers
Rotational viscometers
Nishanth Arunodayam
 

What's hot (20)

Complexation and protein binding
Complexation and protein bindingComplexation and protein binding
Complexation and protein binding
 
Enzyme induction and inhibition
Enzyme induction and inhibitionEnzyme induction and inhibition
Enzyme induction and inhibition
 
Complexation & protein binding
Complexation & protein bindingComplexation & protein binding
Complexation & protein binding
 
kinetics of protein binding.pptx
kinetics of protein binding.pptxkinetics of protein binding.pptx
kinetics of protein binding.pptx
 
Physicochemical properties of drug molecules
Physicochemical properties of drug moleculesPhysicochemical properties of drug molecules
Physicochemical properties of drug molecules
 
Protein Drug Binding
Protein Drug BindingProtein Drug Binding
Protein Drug Binding
 
Surface and interfacial phenomenon
Surface and interfacial  phenomenonSurface and interfacial  phenomenon
Surface and interfacial phenomenon
 
Unit IV MICROMERITICS
Unit IV MICROMERITICSUnit IV MICROMERITICS
Unit IV MICROMERITICS
 
Thixotropy (1) (1)
Thixotropy (1) (1)Thixotropy (1) (1)
Thixotropy (1) (1)
 
Solubility of drugs
Solubility of drugsSolubility of drugs
Solubility of drugs
 
Deformation of solids (Physical Pharmaceutics)
Deformation of solids (Physical Pharmaceutics)Deformation of solids (Physical Pharmaceutics)
Deformation of solids (Physical Pharmaceutics)
 
Ideal solubility parameter (solubility of drug part 2)
Ideal solubility parameter (solubility of drug part 2)Ideal solubility parameter (solubility of drug part 2)
Ideal solubility parameter (solubility of drug part 2)
 
ELIMINATION OF DRUGS BIOPHARMACEUTICS
ELIMINATION OF DRUGS BIOPHARMACEUTICSELIMINATION OF DRUGS BIOPHARMACEUTICS
ELIMINATION OF DRUGS BIOPHARMACEUTICS
 
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th semMedicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
Medicinal chemistry, sympathomimetic agents, unit-2 ,4th sem
 
Ph, buffers & isotonic solution
Ph, buffers & isotonic solutionPh, buffers & isotonic solution
Ph, buffers & isotonic solution
 
Mechanism of solute solvent interaction
Mechanism of solute solvent interactionMechanism of solute solvent interaction
Mechanism of solute solvent interaction
 
kinetics and drug stability
kinetics and drug stability kinetics and drug stability
kinetics and drug stability
 
Causes of Non linear pharmacokinetics
Causes of Non linear pharmacokineticsCauses of Non linear pharmacokinetics
Causes of Non linear pharmacokinetics
 
Suspension, type of suspension, interracial property of suspended particles
Suspension, type of suspension, interracial property of suspended particles Suspension, type of suspension, interracial property of suspended particles
Suspension, type of suspension, interracial property of suspended particles
 
Rotational viscometers
Rotational viscometersRotational viscometers
Rotational viscometers
 

Similar to PROTEIN BINDING

Biopharma
BiopharmaBiopharma
Biopharma
suzon ali
 
Protein binding interactions
Protein binding interactionsProtein binding interactions
Protein binding interactions
MehulJain143
 
protein binding.pptx
protein binding.pptxprotein binding.pptx
protein binding.pptx
VivekKumbhar27
 
PROTEIN BINDING OF DRUGS.pptx
PROTEIN BINDING OF DRUGS.pptxPROTEIN BINDING OF DRUGS.pptx
PROTEIN BINDING OF DRUGS.pptx
gauribhatt96
 
Protein drug binding.ppt
Protein drug binding.pptProtein drug binding.ppt
Protein drug binding.ppt
ram choure
 
Drug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding siteDrug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding site
Arabinda Changmai
 
Drug protein interactions
Drug protein interactionsDrug protein interactions
Drug protein interactions
ShritilekhaDash
 
BIOPHARMACEUTICS & PHARMACOKINETICS BY VAISHNAVI GUPTA.pptx
BIOPHARMACEUTICS & PHARMACOKINETICS BY VAISHNAVI GUPTA.pptxBIOPHARMACEUTICS & PHARMACOKINETICS BY VAISHNAVI GUPTA.pptx
BIOPHARMACEUTICS & PHARMACOKINETICS BY VAISHNAVI GUPTA.pptx
VaishnaviGupta390810
 
method of analysis and protein binding.pptx
method of analysis and protein binding.pptxmethod of analysis and protein binding.pptx
method of analysis and protein binding.pptx
kartikaybandagrate
 
proteindrugbinding-160428055046.pptx
proteindrugbinding-160428055046.pptxproteindrugbinding-160428055046.pptx
proteindrugbinding-160428055046.pptx
ssuser57769b
 
drug interaction
drug interactiondrug interaction
drug interaction
KarthikSwamybm
 
Protein binding of drugs and screening of drugs by physicochemical properties
Protein binding of drugs  and screening of drugs by physicochemical propertiesProtein binding of drugs  and screening of drugs by physicochemical properties
Protein binding of drugs and screening of drugs by physicochemical properties
Bhaswat Chakraborty
 
Protein Binding Of Drug.pptx
Protein Binding Of Drug.pptxProtein Binding Of Drug.pptx
Protein Binding Of Drug.pptx
SkRahabar1
 
Drug intreaction
Drug intreactionDrug intreaction
Drug intreaction
MansiGangwar5
 
drugintreaction-210802120hhhhhhhhhhhhhhh814 (1).pdf
drugintreaction-210802120hhhhhhhhhhhhhhh814 (1).pdfdrugintreaction-210802120hhhhhhhhhhhhhhh814 (1).pdf
drugintreaction-210802120hhhhhhhhhhhhhhh814 (1).pdf
Vaibhavwagh48
 
Pharmacokinitic
PharmacokiniticPharmacokinitic
Pharmacokinitic
IPMS- KMU KPK PAKISTAN
 
Proteinbindingofdrug 150217022700-conversion-gate02
Proteinbindingofdrug 150217022700-conversion-gate02Proteinbindingofdrug 150217022700-conversion-gate02
Proteinbindingofdrug 150217022700-conversion-gate02
MANISH KUMAR
 
Drug interaction
Drug interactionDrug interaction
Drug interaction
Manish Rajput
 
Physico chemical properties of drugs-converted
Physico chemical properties of drugs-convertedPhysico chemical properties of drugs-converted
Physico chemical properties of drugs-converted
N J V S Pavan
 

Similar to PROTEIN BINDING (20)

Biopharma
BiopharmaBiopharma
Biopharma
 
Protein binding interactions
Protein binding interactionsProtein binding interactions
Protein binding interactions
 
protein binding.pptx
protein binding.pptxprotein binding.pptx
protein binding.pptx
 
PROTEIN BINDING OF DRUGS.pptx
PROTEIN BINDING OF DRUGS.pptxPROTEIN BINDING OF DRUGS.pptx
PROTEIN BINDING OF DRUGS.pptx
 
Protein drug binding.ppt
Protein drug binding.pptProtein drug binding.ppt
Protein drug binding.ppt
 
Drug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding siteDrug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding site
 
Drug protein interactions
Drug protein interactionsDrug protein interactions
Drug protein interactions
 
BIOPHARMACEUTICS & PHARMACOKINETICS BY VAISHNAVI GUPTA.pptx
BIOPHARMACEUTICS & PHARMACOKINETICS BY VAISHNAVI GUPTA.pptxBIOPHARMACEUTICS & PHARMACOKINETICS BY VAISHNAVI GUPTA.pptx
BIOPHARMACEUTICS & PHARMACOKINETICS BY VAISHNAVI GUPTA.pptx
 
method of analysis and protein binding.pptx
method of analysis and protein binding.pptxmethod of analysis and protein binding.pptx
method of analysis and protein binding.pptx
 
proteindrugbinding-160428055046.pptx
proteindrugbinding-160428055046.pptxproteindrugbinding-160428055046.pptx
proteindrugbinding-160428055046.pptx
 
drug interaction
drug interactiondrug interaction
drug interaction
 
Protein binding of drugs and screening of drugs by physicochemical properties
Protein binding of drugs  and screening of drugs by physicochemical propertiesProtein binding of drugs  and screening of drugs by physicochemical properties
Protein binding of drugs and screening of drugs by physicochemical properties
 
Protein Binding Of Drug.pptx
Protein Binding Of Drug.pptxProtein Binding Of Drug.pptx
Protein Binding Of Drug.pptx
 
Drug intreaction
Drug intreactionDrug intreaction
Drug intreaction
 
drugintreaction-210802120hhhhhhhhhhhhhhh814 (1).pdf
drugintreaction-210802120hhhhhhhhhhhhhhh814 (1).pdfdrugintreaction-210802120hhhhhhhhhhhhhhh814 (1).pdf
drugintreaction-210802120hhhhhhhhhhhhhhh814 (1).pdf
 
Pharmacokinitic
PharmacokiniticPharmacokinitic
Pharmacokinitic
 
Proteinbindingofdrug 150217022700-conversion-gate02
Proteinbindingofdrug 150217022700-conversion-gate02Proteinbindingofdrug 150217022700-conversion-gate02
Proteinbindingofdrug 150217022700-conversion-gate02
 
Drug interaction
Drug interactionDrug interaction
Drug interaction
 
Protein binding of drugs
Protein binding of drugsProtein binding of drugs
Protein binding of drugs
 
Physico chemical properties of drugs-converted
Physico chemical properties of drugs-convertedPhysico chemical properties of drugs-converted
Physico chemical properties of drugs-converted
 

More from Sneha Pandey

homeopathy system of medicine herbal drug technology
homeopathy system of medicine herbal drug technologyhomeopathy system of medicine herbal drug technology
homeopathy system of medicine herbal drug technology
Sneha Pandey
 
Homeopathic system of medicine and there principle
Homeopathic system of medicine and there principleHomeopathic system of medicine and there principle
Homeopathic system of medicine and there principle
Sneha Pandey
 
Pharmacovigilance role and challenges phased by doctors
Pharmacovigilance role and challenges phased by doctorsPharmacovigilance role and challenges phased by doctors
Pharmacovigilance role and challenges phased by doctors
Sneha Pandey
 
unit 4 Medicinal chemistry 5th semester notes.pdf
unit 4 Medicinal chemistry 5th semester notes.pdfunit 4 Medicinal chemistry 5th semester notes.pdf
unit 4 Medicinal chemistry 5th semester notes.pdf
Sneha Pandey
 
unit 2,pharmacology,chemical test for differentchemical constituents,5th seme...
unit 2,pharmacology,chemical test for differentchemical constituents,5th seme...unit 2,pharmacology,chemical test for differentchemical constituents,5th seme...
unit 2,pharmacology,chemical test for differentchemical constituents,5th seme...
Sneha Pandey
 
Isolation,extraction ,industrial production and uses of herbal plants unit 3n...
Isolation,extraction ,industrial production and uses of herbal plants unit 3n...Isolation,extraction ,industrial production and uses of herbal plants unit 3n...
Isolation,extraction ,industrial production and uses of herbal plants unit 3n...
Sneha Pandey
 
Metabolic pathway unit 1 pharmacology 5th semester
Metabolic pathway unit 1 pharmacology 5th semesterMetabolic pathway unit 1 pharmacology 5th semester
Metabolic pathway unit 1 pharmacology 5th semester
Sneha Pandey
 
Modern methods of extraction unit 5 pharmacology
Modern methods of extraction unit 5 pharmacologyModern methods of extraction unit 5 pharmacology
Modern methods of extraction unit 5 pharmacology
Sneha Pandey
 
"VITAMIN SUPPLEMENTS AND SCHIZOPHRENIA: UNRAVELING THE CONNECTION FOR IMPROVE...
"VITAMIN SUPPLEMENTS AND SCHIZOPHRENIA: UNRAVELING THE CONNECTION FOR IMPROVE..."VITAMIN SUPPLEMENTS AND SCHIZOPHRENIA: UNRAVELING THE CONNECTION FOR IMPROVE...
"VITAMIN SUPPLEMENTS AND SCHIZOPHRENIA: UNRAVELING THE CONNECTION FOR IMPROVE...
Sneha Pandey
 
PARKINSON DISEASE -: Effects of Environmental and Pollution
PARKINSON DISEASE -: Effects of Environmental and PollutionPARKINSON DISEASE -: Effects of Environmental and Pollution
PARKINSON DISEASE -: Effects of Environmental and Pollution
Sneha Pandey
 
Climate change and neurodegenerative disease
Climate change and neurodegenerative diseaseClimate change and neurodegenerative disease
Climate change and neurodegenerative disease
Sneha Pandey
 
Environmental pollutants and Alzheimer's disease
Environmental pollutants and Alzheimer's diseaseEnvironmental pollutants and Alzheimer's disease
Environmental pollutants and Alzheimer's disease
Sneha Pandey
 
Late onset Alzheimer's disease
Late onset Alzheimer's diseaseLate onset Alzheimer's disease
Late onset Alzheimer's disease
Sneha Pandey
 
Genetics of Early onset Alzheimer's disease.docx
Genetics of Early onset Alzheimer's disease.docxGenetics of Early onset Alzheimer's disease.docx
Genetics of Early onset Alzheimer's disease.docx
Sneha Pandey
 
Alzheimer's disease biomarkers
 Alzheimer's disease biomarkers Alzheimer's disease biomarkers
Alzheimer's disease biomarkers
Sneha Pandey
 
Parkinson's disease biomarkers.docx
Parkinson's disease biomarkers.docxParkinson's disease biomarkers.docx
Parkinson's disease biomarkers.docx
Sneha Pandey
 
soybean isoflavone in treatment of Alzheimer's disease 1.docx
soybean isoflavone in treatment of Alzheimer's disease 1.docxsoybean isoflavone in treatment of Alzheimer's disease 1.docx
soybean isoflavone in treatment of Alzheimer's disease 1.docx
Sneha Pandey
 
epilepsy.docx
epilepsy.docxepilepsy.docx
epilepsy.docx
Sneha Pandey
 
Legumes Report-12.docx
Legumes Report-12.docxLegumes Report-12.docx
Legumes Report-12.docx
Sneha Pandey
 
blood based biomarkers sneha.docx
blood based biomarkers sneha.docxblood based biomarkers sneha.docx
blood based biomarkers sneha.docx
Sneha Pandey
 

More from Sneha Pandey (20)

homeopathy system of medicine herbal drug technology
homeopathy system of medicine herbal drug technologyhomeopathy system of medicine herbal drug technology
homeopathy system of medicine herbal drug technology
 
Homeopathic system of medicine and there principle
Homeopathic system of medicine and there principleHomeopathic system of medicine and there principle
Homeopathic system of medicine and there principle
 
Pharmacovigilance role and challenges phased by doctors
Pharmacovigilance role and challenges phased by doctorsPharmacovigilance role and challenges phased by doctors
Pharmacovigilance role and challenges phased by doctors
 
unit 4 Medicinal chemistry 5th semester notes.pdf
unit 4 Medicinal chemistry 5th semester notes.pdfunit 4 Medicinal chemistry 5th semester notes.pdf
unit 4 Medicinal chemistry 5th semester notes.pdf
 
unit 2,pharmacology,chemical test for differentchemical constituents,5th seme...
unit 2,pharmacology,chemical test for differentchemical constituents,5th seme...unit 2,pharmacology,chemical test for differentchemical constituents,5th seme...
unit 2,pharmacology,chemical test for differentchemical constituents,5th seme...
 
Isolation,extraction ,industrial production and uses of herbal plants unit 3n...
Isolation,extraction ,industrial production and uses of herbal plants unit 3n...Isolation,extraction ,industrial production and uses of herbal plants unit 3n...
Isolation,extraction ,industrial production and uses of herbal plants unit 3n...
 
Metabolic pathway unit 1 pharmacology 5th semester
Metabolic pathway unit 1 pharmacology 5th semesterMetabolic pathway unit 1 pharmacology 5th semester
Metabolic pathway unit 1 pharmacology 5th semester
 
Modern methods of extraction unit 5 pharmacology
Modern methods of extraction unit 5 pharmacologyModern methods of extraction unit 5 pharmacology
Modern methods of extraction unit 5 pharmacology
 
"VITAMIN SUPPLEMENTS AND SCHIZOPHRENIA: UNRAVELING THE CONNECTION FOR IMPROVE...
"VITAMIN SUPPLEMENTS AND SCHIZOPHRENIA: UNRAVELING THE CONNECTION FOR IMPROVE..."VITAMIN SUPPLEMENTS AND SCHIZOPHRENIA: UNRAVELING THE CONNECTION FOR IMPROVE...
"VITAMIN SUPPLEMENTS AND SCHIZOPHRENIA: UNRAVELING THE CONNECTION FOR IMPROVE...
 
PARKINSON DISEASE -: Effects of Environmental and Pollution
PARKINSON DISEASE -: Effects of Environmental and PollutionPARKINSON DISEASE -: Effects of Environmental and Pollution
PARKINSON DISEASE -: Effects of Environmental and Pollution
 
Climate change and neurodegenerative disease
Climate change and neurodegenerative diseaseClimate change and neurodegenerative disease
Climate change and neurodegenerative disease
 
Environmental pollutants and Alzheimer's disease
Environmental pollutants and Alzheimer's diseaseEnvironmental pollutants and Alzheimer's disease
Environmental pollutants and Alzheimer's disease
 
Late onset Alzheimer's disease
Late onset Alzheimer's diseaseLate onset Alzheimer's disease
Late onset Alzheimer's disease
 
Genetics of Early onset Alzheimer's disease.docx
Genetics of Early onset Alzheimer's disease.docxGenetics of Early onset Alzheimer's disease.docx
Genetics of Early onset Alzheimer's disease.docx
 
Alzheimer's disease biomarkers
 Alzheimer's disease biomarkers Alzheimer's disease biomarkers
Alzheimer's disease biomarkers
 
Parkinson's disease biomarkers.docx
Parkinson's disease biomarkers.docxParkinson's disease biomarkers.docx
Parkinson's disease biomarkers.docx
 
soybean isoflavone in treatment of Alzheimer's disease 1.docx
soybean isoflavone in treatment of Alzheimer's disease 1.docxsoybean isoflavone in treatment of Alzheimer's disease 1.docx
soybean isoflavone in treatment of Alzheimer's disease 1.docx
 
epilepsy.docx
epilepsy.docxepilepsy.docx
epilepsy.docx
 
Legumes Report-12.docx
Legumes Report-12.docxLegumes Report-12.docx
Legumes Report-12.docx
 
blood based biomarkers sneha.docx
blood based biomarkers sneha.docxblood based biomarkers sneha.docx
blood based biomarkers sneha.docx
 

Recently uploaded

Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
Atul Kumar Singh
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
AzmatAli747758
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
BhavyaRajput3
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
GeoBlogs
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
Ashokrao Mane college of Pharmacy Peth-Vadgaon
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
TechSoup
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
Celine George
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
Thiyagu K
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
Jisc
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
GeoBlogs
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
RaedMohamed3
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
Delapenabediema
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
Tamralipta Mahavidyalaya
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
Steve Thomason
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
DeeptiGupta154
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
rosedainty
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
Jisc
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
Celine George
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
bennyroshan06
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
Pavel ( NSTU)
 

Recently uploaded (20)

Language Across the Curriculm LAC B.Ed.
Language Across the  Curriculm LAC B.Ed.Language Across the  Curriculm LAC B.Ed.
Language Across the Curriculm LAC B.Ed.
 
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...Cambridge International AS  A Level Biology Coursebook - EBook (MaryFosbery J...
Cambridge International AS A Level Biology Coursebook - EBook (MaryFosbery J...
 
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCECLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
CLASS 11 CBSE B.St Project AIDS TO TRADE - INSURANCE
 
Fish and Chips - have they had their chips
Fish and Chips - have they had their chipsFish and Chips - have they had their chips
Fish and Chips - have they had their chips
 
Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......Ethnobotany and Ethnopharmacology ......
Ethnobotany and Ethnopharmacology ......
 
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup   New Member Orientation and Q&A (May 2024).pdfWelcome to TechSoup   New Member Orientation and Q&A (May 2024).pdf
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdf
 
Model Attribute Check Company Auto Property
Model Attribute  Check Company Auto PropertyModel Attribute  Check Company Auto Property
Model Attribute Check Company Auto Property
 
Unit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdfUnit 8 - Information and Communication Technology (Paper I).pdf
Unit 8 - Information and Communication Technology (Paper I).pdf
 
The approach at University of Liverpool.pptx
The approach at University of Liverpool.pptxThe approach at University of Liverpool.pptx
The approach at University of Liverpool.pptx
 
The geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideasThe geography of Taylor Swift - some ideas
The geography of Taylor Swift - some ideas
 
Palestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptxPalestine last event orientationfvgnh .pptx
Palestine last event orientationfvgnh .pptx
 
The Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official PublicationThe Challenger.pdf DNHS Official Publication
The Challenger.pdf DNHS Official Publication
 
Home assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdfHome assignment II on Spectroscopy 2024 Answers.pdf
Home assignment II on Spectroscopy 2024 Answers.pdf
 
The Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve ThomasonThe Art Pastor's Guide to Sabbath | Steve Thomason
The Art Pastor's Guide to Sabbath | Steve Thomason
 
Overview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with MechanismOverview on Edible Vaccine: Pros & Cons with Mechanism
Overview on Edible Vaccine: Pros & Cons with Mechanism
 
Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)Template Jadual Bertugas Kelas (Boleh Edit)
Template Jadual Bertugas Kelas (Boleh Edit)
 
Supporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptxSupporting (UKRI) OA monographs at Salford.pptx
Supporting (UKRI) OA monographs at Salford.pptx
 
How to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERPHow to Create Map Views in the Odoo 17 ERP
How to Create Map Views in the Odoo 17 ERP
 
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptxMARUTI SUZUKI- A Successful Joint Venture in India.pptx
MARUTI SUZUKI- A Successful Joint Venture in India.pptx
 
Synthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptxSynthetic Fiber Construction in lab .pptx
Synthetic Fiber Construction in lab .pptx
 

PROTEIN BINDING

  • 2. PROTEIN BINDING ● The phenomenon of complex formation of drug with protein is called protein binding. ● A protein bound drug is neither metabolised nor excreted hence it is pharmacologically inactive. ● Protein + drug = Protein drug complex
  • 3. Protein binding may be divided into two groups- ● Reversible binding- The drug binds the Protein with weak bonds such as- hydrogen bonds or van der waals forces. ● These type of drugs can unbound and shows its therapeutic action.
  • 4. ● Irreversible binding- The drug binds with protein by strong covalent bonding and often a reason for the carcinogenicity and toxicity. ● Order of binding of drug with protein: Albumin > glycoprotein >lipoprotein> globulin
  • 5.
  • 6. ● Binding of drugs to albumin 2.Digoxine 1. Warfarin & site Azapropazone 4.Diazepam sit 3. Tamoxifen site
  • 7.
  • 8. ● Significance of protein binding with drug:- ● Absorption- When there is more protein binding by the drug then it will distrub the absorption equilibrium. ● The rate of absorption is decreased when protein is bind with drug. ● Distribution- The protein bound drug doesn’t cross the BBB, placental barrier and glomerulus. Thus it decrease the distribution of drug.
  • 9. Metabolism- Protein binding decreases the metabolism of drug and enhance the biological half life. Only unbound fraction get metabolised. Elimination- Only the unbound druf is capable of being eliminated. Protein binding prevent the entry of drug to the metabolizing organ (liver) and glomerulus filtration. Systemic solubility of drug – Lipoprotein act as vehicle for hydrophobic drugs like steriods,heparin, oil soluble vitamins.
  • 10. Drug action- Protein binding inactivates the drug because sufficient concentration of drug cannot be build up in the receptor site for action. Diagnisis – The chlorine atom of chloroquine replaced with radiolabeled l-131cab be used to visualise melanomas of eyes and disorders of thyroid gland.
  • 11. Factors affecting protein binding Drug related factors: 1. Physiochemical factors of drug- Binding affinity depend on physical and chemical properties of drug. Increase in lipophilicity Increase the drug binding with the protein. 2. Concentration of drug- Alteration in concentration of drug substance as well as the protein molecules cause alteration in protein binding. At low concentration, most drug may bound to protein. At high concentration, more free drug may present owing to saturation of binding site on protein.
  • 12. 3. Affinity of drug for binding component- ● This depend on affinity of protein molecule to bind to drug. ● Eg. Digoxine hascmore affinity for protein of cardiac muscle than those of skeletal muscles. ● Factors related to protein: 1.Physiochemical property- Lipoprotein bind with lipophilic drug. 2. Concentration of protein- Disease state affect the concentration of protein in blood. It Increase the concentration of protein and protein binding in the body.
  • 13. 3.No. Of binding sites- Presence of more binding sites in protein increase protein binding of drug. Eg Albumin has more no. Of binding site. ● Factors related to age: 1.Age- Neonata have low albumin content thus less drug binding. 2. Disease state- Disease states increase the Albumin thus increse protein binding.
  • 14. Method of measuring the unbound drug concentration ● Equilibrium dialysis method ● In this method the Albumin is placed in visking cellulose bag and drug in different concentration is placed in the outside vessel. ● As the dialysis continue, the drug molecules permeate through the membrane and enter into the bag. ● As a result the dryg protein binding is observed. Albumin being macromolecules can’t pass through the membrane to outside vessel. ● As time ellapsis more amount of drug permeate and available in the bag. ● If binding occurs the drug concentration in the body containing protein should be greater than its concentration in the outside vessel.
  • 16. 2. Dynamic dialysis method: ● The apparatus consist of a 400ml jacketed (with a temperature control) beaker into which 200ml of buffer solution is placed. ● Around 70ml of drug (blank) and drug protein solution is placed in a dialysis bag and suspended in the buffer solution. The solution is is stir continuously. ● During dialysis the free drug present in the bag permeate through the membrane and reaches the buffer solution. ● Such a transport shift the equilibrium in favour of full drug molecules in the bag. ● Every 5 or 10 mins. Sample of solution are withdrawn from the beaker and an equivalent quantity of buffer solution is return to the beaker ● The amount of drug present in the solution is estimated by a suitable method (UV rays)